Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Geltim LP vs Xalatan in Glaucoma and Ocular Hypertension
NCT01155219Phase 4Completed
- Sponsor
- Laboratoires Théa
- Start
- Jul 2008
- Primary completion
- Jul 2009
- Countries
- 1
01
Overview
Phase 4, randomised trial of Geltim LP in Primary Open Angle Glaucoma (POAG) and ocular hypertension (2 arms), sponsored by Laboratoires Théa. Primary endpoint: Ocular Tolerance at 84 days. Started Jul 2008; status: completed.
02
Drugs
Geltim LP
03
Conditions
Primary Open Angle Glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01155219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155219.